This is a prospective randomized open study, which aims to evaluate the benefit of a connected watch to help people aged 65 years and older to withdraw from BZD over a six-month period, compared with classical withdrawal (e.g without connected watch). The study will include 100 patients, 50 in the control group and 50 in the intervention group.
Participants will be identified during a 12-month period through either external geriatric consultations or during a brief hospitalisation.
Unassisted mobility (1/1 for the locomotion item on KATZ Activities of Daily Living scale)
Mini-Mental State Examination (MMSE) ≥ 20
With a daily consumption of benzodiazepine for more than 3 months
Smartphone and/or tablet with internet connection
Patient under legal protection
Patient refuses to participate
Patient does not speak French
Parallel
connected watch
Deviceconnected watch that provide to patients with information on their sleep quality and their performed activities
success to stop or reduce benzodiazepine consumption
success to stop benzodiazepine consumption (no more intake) or reduce benzodiazepine consumption (decrease in dosage of more than 25% or non-daily intake)
Click on the lead sponsor to view all of their trials.
